AstraZeneca Antibody Drug Prevents Symptomatic Covid-19 in Trial

The company said it would seek regulatory approval after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential alternative to vaccines for people who refuse shots or for whom they aren’t effective.

Biden’s Soft Infrastructure Agenda May Not Boost Growth

The president has sold soft infrastructure such as in child care,...

How the Pandemic Has Changed the Way High-End Art Is Sold

Private sales at Sotheby’s and Christie’s took off, as live-auction revenues...

Facebook to Hire 10,000 Workers in EU to Build Up ‘Metaverse’

Facebook is planning to create 10,000 jobs in the European Union...

China Third-Quarter Economic Growth Slows Sharply to 4.9%

China’s economy grew 4.9% in the third quarter from a year...